Our data showed that miR-1263 was downregulated in the cytoplasm and inhibited the growth of HCC cells by targeting CDK6, which is indispensable for cell cycle progression to the G1 phase and G1/S transition (17). The gene discussed is CDK6; the disease is hepatocellular carcinoma.